| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000016442 |
| Receipt No. | R000019095 |
| Official scientific title of the study | A clinical study investigating the safety and efficacy of daikenchuto for the treatment of abdominal bloating. |
| Date of disclosure of the study information | 2015/02/04 |
| Last modified on | 2016/11/29 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A clinical study investigating the safety and efficacy of daikenchuto for the treatment of abdominal bloating. | |
| Title of the study (Brief title) | A clinical study investigating the safety and efficacy of daikenchuto for the treatment of abdominal bloating. | |
| Region |
|
|
| Condition | ||
| Condition | Patients with abdominal bloating | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate the efficacy and safety of daikenchuto for the treatment of abdominal bloating in patients. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Self-reported abdominal bloating rating |
| Key secondary outcomes | Self-reported satisfaction rating with treatment
SF-8 GSRS Bristol stool scale Abdominal girth Rate of Sympathetic /parasympathetic Salivary amylase activity |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Oral administration of Daikenchuto 15.0g/day for 4weeks. | |
| Interventions/Control_2 | Oral administration of Biofermin 3T/day for 4weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Self-reported abdominal bloating rating >= 4
20 <= years old <= 84 Male and female Outpatients Provides written informed consent |
|||
| Key exclusion criteria | Patients receiving daikenchuto or other Japanese traditional herbal medicine within 4 weeks before enrolled in this study
If not stable doses of the follow medications are taken for at least 2 weeks before enrolled to this study: acid suppressant, prokinetics, calcium polycarbophil, anticholinergic drug, laxative, antidepressant, anti-anxiety agent. Patients with organic lesion like cancer. Patients with serious coexisting disease (e.g. Hepatic, renal, cardiac, hematological, or metabolic disorder). Lactating or pregnant mother or women who wish to become pregnant during the study period. Determined not applicable for this study by the investigator. |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Mika Yuki |
| Organization | Izumo-City General Medical Center |
| Division name | Division of Internal Medicine |
| Address | 613 Nadabun-cho, Izumo City, Shimane Prefecture |
| TEL | 0853-63-5111 |
| yuuki-mika@izumo-hospital.jp | |
| Public contact | |
| Name of contact person | Mika Yuki |
| Organization | Izumo-City General Medical Center |
| Division name | Division of Internal Medicine |
| Address | Izumo City, Shimane Prefecture |
| TEL | 0853-63-5111 |
| Homepage URL | |
| yuuki-mika@izumo-hospital.jp | |
| Sponsor | |
| Institute | Izumo-City General Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tsumura & Co. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019095 |